Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Biosimilars—Curb Your Enthusiasm

Biosimilars—Curb Your Enthusiasm This Viewpoint discusses why the market for biosimilars and the cost savings related to their use have remained smaller than expected in the United States and suggests ways to rectify this situation. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Oncology American Medical Association

Biosimilars—Curb Your Enthusiasm

Yang, Y. Tony; Chen, Brian; Bennett, Charles L.
JAMA Oncology , Volume 3 (11) – Nov 8, 2017
Download PDF
2 pages

Loading next page...
 
/lp/american-medical-association/biosimilars-curb-your-enthusiasm-VCDtdysCvD

References (2)

Publisher
American Medical Association
Copyright
Copyright 2017 American Medical Association. All Rights Reserved.
ISSN
2374-2437
eISSN
2374-2445
DOI
10.1001/jamaoncol.2017.1530
Publisher site
See Article on Publisher Site

Abstract

This Viewpoint discusses why the market for biosimilars and the cost savings related to their use have remained smaller than expected in the United States and suggests ways to rectify this situation.

Journal

JAMA Oncology – American Medical Association

Published: Nov 8, 2017

There are no references for this article.